You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AGN-190584

Showing 1 - 25 of 53
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Presbyopia Trial (AGN-190584)

Not yet recruiting
  • Presbyopia
  • AGN-190584
  • (no location specified)
Nov 21, 2022

Presbyopia Trial in Brisbane (AGN-190584)

Completed
  • Presbyopia
  • AGN-190584
  • Brisbane, Queensland, Australia
    School of Optometry and Vision Science, Queensland University of
Feb 11, 2022

Presbyopia Trial in United States (AGN-190584, Vehicle)

Completed
  • Presbyopia
  • Bakersfield, California
  • +22 more
Feb 14, 2022

Presbyopia Trial in United States (AGN-190584, Vehicle)

Withdrawn
  • Presbyopia
  • Dothan, Alabama
  • +31 more
Jun 24, 2022

Presbyopia Trial in United States (Pilocarpine HCl Ophthalmic Solution, Vehicle)

Completed
Has Results
  • Presbyopia
  • Pilocarpine HCl Ophthalmic Solution
  • Vehicle
  • Dothan, Alabama
  • +34 more
Nov 27, 2021

Presbyopia Trial in United States (Vehicle, Pilocarpine HCl Ophthalmic Solution)

Completed
Has Results
  • Presbyopia
  • Vehicle
  • Pilocarpine HCl Ophthalmic Solution
  • Chandler, Arizona
  • +35 more
Nov 27, 2021

Presbyopia Trial in United States (AGN-199201 ophthalmic solution, AGN-190584 ophthalmic solution, AGN-190584 vehicle)

Completed
Has Results
  • Presbyopia
  • AGN-199201 ophthalmic solution
  • +4 more
  • Artesia, California
  • +19 more
Dec 1, 2020

Presbyopia Trial in United States (AGN-241622, AGN-190584, Vehicle)

Recruiting
  • Presbyopia
  • Inglewood, California
  • +10 more
Dec 8, 2021

Presbyopia Trial in United States (AGN-199201 ophthalmic solution, AGN-190584 ophthalmic solution, AGN-199201 Vehicle)

Completed
Has Results
  • Presbyopia
  • AGN-199201 ophthalmic solution
  • +3 more
  • Arcadia, California
  • +24 more
Dec 1, 2020

Moderate to Severe Glabellar Lines Trial (AGN-151586, Placebo)

Not yet recruiting
  • Moderate to Severe Glabellar Lines
  • (no location specified)
Nov 22, 2023

Glabellar Lines Trial in Canada, United States (AGN-151586, Placebo)

Recruiting
  • Glabellar Lines
  • Scottsdale, Arizona
  • +16 more
Aug 15, 2022

Glabellar Lines Trial in Worldwide (AGN-151586, Placebo)

Recruiting
  • Glabellar Lines
  • Birmingham, Alabama
  • +38 more
Aug 15, 2022

Glabellar Lines Trial in United States (AGN-151586, BOTOX, Placebo)

Not yet recruiting
  • Glabellar Lines
  • Newport Beach, California
  • +9 more
Aug 9, 2022

Open-angle Glaucoma, Ocular Hypertension Trial in Japan, United States (AGN-193408 SR, Lumigan, Sham Administration)

Recruiting
  • Open-angle Glaucoma
  • Ocular Hypertension
  • AGN-193408 SR
  • +3 more
  • Inglewood, California
  • +27 more
Oct 4, 2022

Depressive Disorder, Major Trial in United States (AGN-241751, Placebo)

Completed
Has Results
  • Depressive Disorder, Major
  • Fayetteville, Arkansas
  • +24 more
Aug 1, 2022

Glabellar Lines Trial in Puerto Rico, United States (AGN-151586)

Recruiting
  • Glabellar Lines
  • Birmingham, Alabama
  • +43 more
Jul 19, 2022

Post-Operative Atrial Fibrillation Trial in Worldwide (AGN-151607, Placebo)

Active, not recruiting
  • Post-Operative Atrial Fibrillation
  • Stanford, California
  • +31 more
Apr 8, 2022

Prostate Cancer Trial (AGN-CognI.Q)

Recruiting
  • Prostate Cancer
  • Hershey, Pennsylvania
    Penn State Cancer Institute
Nov 15, 2022

Glabellar Lines Trial in United States (AGN-151586, Placebo)

Completed
  • Glabellar Lines
  • Fremont, California
  • +8 more
Jul 12, 2021

Plaque Psoriasis Trial in United States (AGN-242428, Placebo)

Terminated
Has Results
  • Plaque Psoriasis
  • Birmingham, Alabama
  • +14 more
Mar 10, 2021

Neuralgia, Postherpetic Trial in Worldwide (AGN-214868, AGN-214868 Placebo (Vehicle))

Terminated
Has Results
  • Neuralgia, Postherpetic
  • Mesa, Arizona
  • +68 more
Dec 19, 2019

Rosacea, Erythema Trial in Austin (AGN-199201 Formulation A, AGN-199201 Formulation B, AGN-199201 Formulation C)

Completed
Has Results
  • Rosacea
  • Erythema
  • AGN-199201 Formulation A
  • +3 more
  • Austin, Texas
    (unnamed)
Nov 15, 2019

Erythema, Rosacea Trial in Portland (Oxymetazoline HCL Cream 1.0%)

Completed
Has Results
  • Erythema
  • Rosacea
  • Oxymetazoline HCL Cream 1.0%
  • Portland, Oregon
    (unnamed)
Nov 15, 2019

Erythema, Rosacea Trial in Lynchburg (AGN-199201, Vehicle to AGN-199201)

Completed
Has Results
  • Erythema
  • Rosacea
  • Lynchburg, Virginia
    (unnamed)
Nov 15, 2019

Rosacea, Erythema Trial in Austin (AGN-199201 Dose A, AGN-199201 Dose B, AGN-199201 Dose C)

Completed
Has Results
  • Rosacea
  • Erythema
  • AGN-199201 Dose A
  • +3 more
  • Austin, Texas
    (unnamed)
Nov 15, 2019